颅内肿瘤手术切除后纤维蛋白原缺乏:患病率、危险因素及预后。

Surgical neurology international Pub Date : 2025-05-30 eCollection Date: 2025-01-01 DOI:10.25259/SNI_125_2025
Firas Kalai, Olfa Faten, Sabrine Ben Brahem, Ichraf Ardhaoui, Lotfi Rebai
{"title":"颅内肿瘤手术切除后纤维蛋白原缺乏:患病率、危险因素及预后。","authors":"Firas Kalai, Olfa Faten, Sabrine Ben Brahem, Ichraf Ardhaoui, Lotfi Rebai","doi":"10.25259/SNI_125_2025","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Postoperative fibrinogen deficiency after surgical removal of a brain tumor can cause potentially serious complications, such as intracranial hematoma, and worsen the patient's outcome. Our study aimed to determine the prevalence of hypofibrinogenemia after resection of intracranial tumor, to identify the risk factors for this abnormality, and to evaluate the prognosis of patients with this hemostasis disorder.</p><p><strong>Methods: </strong>We conducted a prospective, descriptive study including 120 patients who presented for brain tumor resection without preoperative fibrinogen deficiency and had given their consent to participate in the study. We determined the fibrinogen level the day before the procedure, at 1 h and 24 h postoperatively. We determined the prevalence of postoperative fibrinogen deficiency. Postoperative complications, neurological status of the patient, and mortality at 3 months were subsequently recorded.</p><p><strong>Results: </strong>Forty-eight patients presented postoperative fibrinogen deficiency with a high prevalence of 40%. Our study identified three predictive independent risk factors of fibrinogen deficiency after surgical resection of brain tumor: histological type of meningioma (<i>P</i> = 0.015), prolonged duration of surgery (more than 195 min) (<i>P</i> = 0.045), and use of surgicel as a hemostatic product intraoperatively (<i>P</i> = 0.009). Postoperative hematoma and sensory-motor deficit were significantly associated with postoperative fibrinogen deficiency (<i>P</i> < 0.001). Patients with postoperative hypofibrinogenemia had worse Glasgow Outcome Scale-Extended at discharge and after 3 months. On the other hand, fibrinogen deficiency after surgical removal of the intracranial tumor was not significantly associated with increased postoperative mortality.</p><p><strong>Conclusion: </strong>We found a high prevalence of hypofibrinogenemia after brain tumor resection (40%). This anomaly increases the risk of intracranial hematoma. It, therefore, deserves the attention of the practitioner to correct it rapidly and avoid its potentially serious complications.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"16 ","pages":"204"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134848/pdf/","citationCount":"0","resultStr":"{\"title\":\"Postoperative fibrinogen deficiency after surgical removal of intracranial tumors: Prevalence, risk factors and prognosis.\",\"authors\":\"Firas Kalai, Olfa Faten, Sabrine Ben Brahem, Ichraf Ardhaoui, Lotfi Rebai\",\"doi\":\"10.25259/SNI_125_2025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Postoperative fibrinogen deficiency after surgical removal of a brain tumor can cause potentially serious complications, such as intracranial hematoma, and worsen the patient's outcome. Our study aimed to determine the prevalence of hypofibrinogenemia after resection of intracranial tumor, to identify the risk factors for this abnormality, and to evaluate the prognosis of patients with this hemostasis disorder.</p><p><strong>Methods: </strong>We conducted a prospective, descriptive study including 120 patients who presented for brain tumor resection without preoperative fibrinogen deficiency and had given their consent to participate in the study. We determined the fibrinogen level the day before the procedure, at 1 h and 24 h postoperatively. We determined the prevalence of postoperative fibrinogen deficiency. Postoperative complications, neurological status of the patient, and mortality at 3 months were subsequently recorded.</p><p><strong>Results: </strong>Forty-eight patients presented postoperative fibrinogen deficiency with a high prevalence of 40%. Our study identified three predictive independent risk factors of fibrinogen deficiency after surgical resection of brain tumor: histological type of meningioma (<i>P</i> = 0.015), prolonged duration of surgery (more than 195 min) (<i>P</i> = 0.045), and use of surgicel as a hemostatic product intraoperatively (<i>P</i> = 0.009). Postoperative hematoma and sensory-motor deficit were significantly associated with postoperative fibrinogen deficiency (<i>P</i> < 0.001). Patients with postoperative hypofibrinogenemia had worse Glasgow Outcome Scale-Extended at discharge and after 3 months. On the other hand, fibrinogen deficiency after surgical removal of the intracranial tumor was not significantly associated with increased postoperative mortality.</p><p><strong>Conclusion: </strong>We found a high prevalence of hypofibrinogenemia after brain tumor resection (40%). This anomaly increases the risk of intracranial hematoma. It, therefore, deserves the attention of the practitioner to correct it rapidly and avoid its potentially serious complications.</p>\",\"PeriodicalId\":94217,\"journal\":{\"name\":\"Surgical neurology international\",\"volume\":\"16 \",\"pages\":\"204\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134848/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical neurology international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/SNI_125_2025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical neurology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/SNI_125_2025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:脑肿瘤手术切除后纤维蛋白原缺乏可导致潜在的严重并发症,如颅内血肿,并使患者预后恶化。我们的研究旨在确定颅内肿瘤切除术后低纤维蛋白原血症的患病率,确定这种异常的危险因素,并评估这种止血障碍患者的预后。方法:我们进行了一项前瞻性描述性研究,纳入了120例术前无纤维蛋白原缺乏并同意参加研究的脑肿瘤切除术患者。我们在手术前一天、术后1小时和24小时测定纤维蛋白原水平。我们确定了术后纤维蛋白原缺乏的发生率。随后记录术后并发症、患者神经系统状况和3个月死亡率。结果:48例患者术后出现纤维蛋白原缺乏,发生率高达40%。我们的研究确定了脑肿瘤手术切除后纤维蛋白原缺乏的三个预测独立危险因素:脑膜瘤的组织学类型(P = 0.015)、手术时间延长(超过195分钟)(P = 0.045)和术中使用外科止血产品(P = 0.009)。术后血肿和感觉运动障碍与术后纤维蛋白原缺乏显著相关(P < 0.001)。术后低纤维蛋白原血症患者在出院时和3个月后的格拉斯哥结局量表延长更差。另一方面,颅内肿瘤手术切除后纤维蛋白原缺乏与术后死亡率增加无显著相关。结论:我们发现脑肿瘤切除术后低纤维蛋白原血症的发生率很高(40%)。这种异常增加了颅内血肿的风险。因此,应该引起医生的注意,迅速纠正它,避免其潜在的严重并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Postoperative fibrinogen deficiency after surgical removal of intracranial tumors: Prevalence, risk factors and prognosis.

Background: Postoperative fibrinogen deficiency after surgical removal of a brain tumor can cause potentially serious complications, such as intracranial hematoma, and worsen the patient's outcome. Our study aimed to determine the prevalence of hypofibrinogenemia after resection of intracranial tumor, to identify the risk factors for this abnormality, and to evaluate the prognosis of patients with this hemostasis disorder.

Methods: We conducted a prospective, descriptive study including 120 patients who presented for brain tumor resection without preoperative fibrinogen deficiency and had given their consent to participate in the study. We determined the fibrinogen level the day before the procedure, at 1 h and 24 h postoperatively. We determined the prevalence of postoperative fibrinogen deficiency. Postoperative complications, neurological status of the patient, and mortality at 3 months were subsequently recorded.

Results: Forty-eight patients presented postoperative fibrinogen deficiency with a high prevalence of 40%. Our study identified three predictive independent risk factors of fibrinogen deficiency after surgical resection of brain tumor: histological type of meningioma (P = 0.015), prolonged duration of surgery (more than 195 min) (P = 0.045), and use of surgicel as a hemostatic product intraoperatively (P = 0.009). Postoperative hematoma and sensory-motor deficit were significantly associated with postoperative fibrinogen deficiency (P < 0.001). Patients with postoperative hypofibrinogenemia had worse Glasgow Outcome Scale-Extended at discharge and after 3 months. On the other hand, fibrinogen deficiency after surgical removal of the intracranial tumor was not significantly associated with increased postoperative mortality.

Conclusion: We found a high prevalence of hypofibrinogenemia after brain tumor resection (40%). This anomaly increases the risk of intracranial hematoma. It, therefore, deserves the attention of the practitioner to correct it rapidly and avoid its potentially serious complications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信